Question 1

Why do benzodiazepines cause both anxiolysis and amnesia - can I separate those effects?

Accepted Answer

GABA-A receptors contain multiple α subunit isoforms (α1, α2, α3, α5) that mediate distinct effects: α1 drives sedation and amnesia; α2/α3 mediate anxiolysis; α5 affects cognition and memory. Current benzodiazepines are non-selective, hitting all subtypes simultaneously, making amnesia inseparable from anxiolysis with available agents. Alprazolam's short half-life (6–12 hours) creates rapid onset/offset cycles that amplify interdose withdrawal and abuse potential. Clonazepam's longer half-life (18–50 hours) produces smoother levels and lower abuse risk. Investigational α2/α3-selective GABA-A modulators (e.g., ENX-102) aim to separate anxiolysis from sedation and amnesia.

Question 2

What are the GABA-A receptor subtypes and which ones mediate anxiolysis vs sedation?

Accepted Answer

GABA-A receptors contain multiple α subunit isoforms (α1, α2, α3, α5) that mediate distinct effects: α1 drives sedation and amnesia; α2/α3 mediate anxiolysis; α5 affects cognition and memory. Current benzodiazepines are non-selective, hitting all subtypes simultaneously, making amnesia inseparable from anxiolysis with available agents. Alprazolam's short half-life (6–12 hours) creates rapid onset/offset cycles that amplify interdose withdrawal and abuse potential. Clonazepam's longer half-life (18–50 hours) produces smoother levels and lower abuse risk. Investigational α2/α3-selective GABA-A modulators (e.g., ENX-102) aim to separate anxiolysis from sedation and amnesia.

Question 3

Why are short-acting benzodiazepines more prone to abuse than long-acting?

Accepted Answer

GABA-A receptors contain multiple α subunit isoforms (α1, α2, α3, α5) that mediate distinct effects: α1 drives sedation and amnesia; α2/α3 mediate anxiolysis; α5 affects cognition and memory. Current benzodiazepines are non-selective, hitting all subtypes simultaneously, making amnesia inseparable from anxiolysis with available agents. Alprazolam's short half-life (6–12 hours) creates rapid onset/offset cycles that amplify interdose withdrawal and abuse potential. Clonazepam's longer half-life (18–50 hours) produces smoother levels and lower abuse risk. Investigational α2/α3-selective GABA-A modulators (e.g., ENX-102) aim to separate anxiolysis from sedation and amnesia.

Question 4

Why is clonazepam preferred for taper over alprazolam?

Accepted Answer

GABA-A receptors contain multiple α subunit isoforms (α1, α2, α3, α5) that mediate distinct effects: α1 drives sedation and amnesia; α2/α3 mediate anxiolysis; α5 affects cognition and memory. Current benzodiazepines are non-selective, hitting all subtypes simultaneously, making amnesia inseparable from anxiolysis with available agents. Alprazolam's short half-life (6–12 hours) creates rapid onset/offset cycles that amplify interdose withdrawal and abuse potential. Clonazepam's longer half-life (18–50 hours) produces smoother levels and lower abuse risk. Investigational α2/α3-selective GABA-A modulators (e.g., ENX-102) aim to separate anxiolysis from sedation and amnesia.

PsychHQ

GABA-A Receptor Subtypes and Benzodiazepine Selectivity: Why Amnesia Follows Anxiolysis